IRCT20190116042379N1招募中3 期
The protective effect of Thiamine (vitamin B1) for Bortezomib induced peripheral neuropathy in multiple myeloma
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •who were suspected to receive Bortezomib based chemotherapy regimen
排除标准
- •do not have interfering factors such as: Previous history of symptomatic peripheral neuropathy, Diabetes mellitus, End stage renal disease, history of alcohol abuse, and any other neuromuscular disease
研究者
相似试验
已完成
2 期
Vitamin B1 (thiamine) administration in enterally-fed critically ill patients with hypophosphatemia: A prospective, randomised clinical trialHypophosphatemiaCritical illnessenteral nutritionMetabolic and Endocrine - Other metabolic disordersDiet and Nutrition - Other diet and nutrition disordersThiamine deficiencyACTRN12619000121167Royal Melbourne Hospital90
已完成
3 期
The effect of vitamin B1 (thiamine) on blood pressure, lipid profile, liver enzymes and fasting blood sugar in the military with metabolic syndromeMetabolic syndrome.Endocrine, nutritional and metabolic diseasesE00-E90IRCT20180201038585N5Bagheiat-allah University of Medical Sciences116
已完成
1 期
Effect of thiamine tablet ( B 1) on general health and treatment success in infertile women with polycystic ovary syndromCondition 1: polycystic ovarian syndrom. Condition 2: Female infertility.IRCT201510266917N3Vice chencelor for research, Iran Nursing and Midwifry School, Iran University of Medical Science64
已完成
2 期
Thiamine supplementation in type 2 diabetesType 2 diabetes mellitusNutritional, Metabolic, EndocrineNon-insulin-dependent diabetes mellitusISRCTN30703970Portsmouth Hospitals NHS Trust (UK)34
进行中（未招募）
不适用
Oral thiamine (Vitamin B1) supplementation in subjects with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled crossover trial assessing biophysical markers of endothelial function, oxidant stress, insulin sensitivity and vascular inflammation - Thiamine supplementation in type 2 diabetes.Type 2 diabetesEUCTR2009-017537-21-GBPortsmouth Hospitals NHS Trust34